Higher versus lower sodium intake for preterm infants

Chan, WC; Chua, Michele Y. K.; Teo, Edward; Osborn, David A; Birch, Pita

doi:10.1002/14651858.cd012642

Cited by 7 publications

(5 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Many preterm (about 10 % of babies) and some full-term babies are at risk of hyponatraemia and receive Na supplementation to ensure proper growth and neurological and cognitive development (31,(84)(85)(86)(87) . The severity of the obligatory neonatal dehydration and Na loss predicts the Na content of the diet we will compose in childhood and possibly beyond (36)(37)(38)88) (Fig.…”

Section: Salt Need Needs Investigationmentioning

confidence: 99%

Salt need needs investigation

Leshem

2020

Br J Nutr

View full text Add to dashboard Cite

AbstractExpensive and extensive studies on the epidemiology of excessive Na intake and its pathology have been conducted over four decades. The resultant consensus that dietary Na is toxic, as well as the contention that it is less so, ignores the root cause of the attractiveness of salted food. The extant hypotheses are that most Na is infiltrated into our bodies via heavily salted industrialised food without our knowledge and that mere exposure early in life determines lifelong intake. However, these hypotheses are poorly evidenced and are meagre explanations for the comparable salt intake of people worldwide despite their markedly different diets. The love of salt begins at birth for some, vacillates in infancy, climaxes during adolescent growth, settles into separate patterns for men and women in adulthood and, with age, fades for some and persists for others. Salt adds flavour to food. It sustains and protects humans in exertion, may modulate their mood and contributes to their ailments. It may have as yet unknown benefits that may promote its delectability, and it generates controversy. An understanding of the predilection for salt should allow a more evidence-based and effective reduction of the health risks associated with Na surfeit and deficiency. The purpose of this brief review is to show the need for research into the determinants of salt intake by summarising the little we know.

show abstract

Section: Salt Need Needs Investigationmentioning

confidence: 99%

Salt need needs investigation

Leshem

2020

Br J Nutr

View full text Add to dashboard Cite

show abstract

“…A Cochrane review assessing the benefits and harms of higher versus lower sodium intakes in preterm infants is currently underway. 16 The Consensus Group agreed on minimal potassium intake using starter PN formulation, with an increase in standard formulations to a maximum 3.0 mmol/kg/d in preterm and 2.7 mmol/kg/day in term infants (LOE III-2, GOR C). This is unchanged from the previous consensus and complies with AAP and ESPGHAN 2005 recommendations.…”

Section: Sodium Potassium and Chloridementioning

confidence: 99%

Standardised neonatal parenteral nutrition formulations – Australasian Neonatal Parenteral Nutrition Consensus update 2017

Bolisetty

Osborn

Schindler

et al. 2020

Preprint

Self Cite

View full text Add to dashboard Cite

Background: The first consensus standardised neonatal parenteral nutrition formulations were implemented in many neonatal units in Australia in 2012. The current update involving 49 units from Australia, New Zealand, Singapore, Malaysia and India was conducted between September 2015 and December 2017 with the aim to review and update the 2012 formulations and guidelines. Methods: A systematic review of available evidence for each parenteral nutrient was undertaken and new standardised formulations and guidelines were developed. Results: Five existing preterm Amino acid-Dextrose formulations have been modified and two new concentrated Amino acid-Dextrose formulations added to optimise amino acid and nutrient intake according to gestation. Organic phosphate has replaced inorganic phosphate allowing for an increase in calcium and phosphate content, and acetate reduced. Lipid emulsions are unchanged, with both SMOFlipid (Fresenius Kabi, Australia) and ClinOleic (Baxter Healthcare, Australia) preparations included. The physicochemical compatibility and stability of all formulations have been tested and confirmed. Guidelines to standardise the parenteral nutrition clinical practice across facilities have also been developed. Conclusions: The 2017 PN formulations and guidelines developed by the 2017 Neonatal Parenteral Nutrition Consensus Group offer concise and practical instructions to clinicians on how to implement current and up-to-date evidence based PN to the NICU population.

show abstract

“…A Cochrane review assessing the benefits and harms of higher versus lower sodium intakes in preterm infants is currently underway. 15 The consensus group agreed on minimal potassium intake using starter PN formulation, with an increase in standard formulations to a maximum 3.0 mmol/kg/d in preterm and 2.7 mmol/kg/day in term infants (LOE III-2, GOR C). This is unchanged from the previous consensus and complies with AAP and ESPGHAN recommendations.…”

Section: Sodium Potassium and Chloridementioning

confidence: 99%

Standardised neonatal parenteral nutrition formulations – Australasian Neonatal Parenteral Nutrition Consensus update 2017

Bolisetty

Osborn

Schindler

et al. 2019

Preprint

Self Cite

View full text Add to dashboard Cite

The first consensus standardised neonatal parenteral nutrition formulations were implemented in many neonatal units in Australia in 2012. The current update involving 49 units from Australia, New Zealand, Singapore, Malaysia and India was conducted between September 2015 and December 2017 with the aim to review and update the 2012 formulations and guidelines. Methods: A systematic review of available evidence for each parenteral nutrient was undertaken and new standardised formulations and guidelines were developed. Results: Five existing preterm Amino acid-Dextrose formulations have been modified and two new concentrated Amino acid-Dextrose formulations added to optimise amino acid and nutrient intake according to gestation. Organic phosphate has replaced inorganic phosphate allowing for an increase in calcium and phosphate content, and acetate reduced. Lipid emulsions are unchanged, with both SMOFlipid and ClinOleic preparations included. The physicochemical compatibility and stability of all formulations have been tested and confirmed. Guidelines to standardise the parenteral nutrition clinical practice across facilities have also been developed. Conclusions: Formulations and guidelines to standardise parenteral nutrition practice across the Australasian region have the potential to improve nutrition and clinical outcomes of neonates. Standardisation can also result in cost savings, quality improvement and error minimisation in PN prescribing and ordering.

show abstract

Higher versus lower sodium intake for preterm infants

Cited by 7 publications

References 43 publications

Salt need needs investigation

Salt need needs investigation

Standardised neonatal parenteral nutrition formulations – Australasian Neonatal Parenteral Nutrition Consensus update 2017

Standardised neonatal parenteral nutrition formulations – Australasian Neonatal Parenteral Nutrition Consensus update 2017

Contact Info

Product

Resources

About